These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22012244)

  • 1. Transfusions, major bleeding, and prevention of venous thromboembolism with enoxaparin or fondaparinux in thoracic surgery.
    Girard P; Demaria J; Lillo-Le Louët A; Caliandro R; Le Guillou JL; Crespin M; de Sanctis A; Stern JB
    Thromb Haemost; 2011 Dec; 106(6):1109-16. PubMed ID: 22012244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fondaparinux or enoxaparin: a comparative study of postoperative bleeding in coronary artery bypass grafting surgery.
    Landenhed M; Johansson M; Erlinge D; Olsson ML; Bjursten H
    Scand Cardiovasc J; 2010 Apr; 44(2):100-6. PubMed ID: 19961287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial.
    Eriksson BI; Dahl OE; Huo MH; Kurth AA; Hantel S; Hermansson K; Schnee JM; Friedman RJ;
    Thromb Haemost; 2011 Apr; 105(4):721-9. PubMed ID: 21225098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
    Reeves D; Liu CY
    J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism prevention with fondaparinux 1.5 mg in renally impaired patients undergoing major orthopaedic surgery. A real-world, prospective, multicentre, cohort study.
    Mismetti P; Samama CM; Rosencher N; Vielpeau C; Nguyen P; Deygas B; Presles E; Laporte S;
    Thromb Haemost; 2012 Jun; 107(6):1151-60. PubMed ID: 22476471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.
    Bauer KA; Eriksson BI; Lassen MR; Turpie AG;
    N Engl J Med; 2001 Nov; 345(18):1305-10. PubMed ID: 11794149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge.
    Fanikos J; Rao A; Seger AC; Piazza G; Catapane E; Chen X; Goldhaber SZ
    Am J Med; 2011 Dec; 124(12):1143-50. PubMed ID: 22114828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does ambulation modify venous thromboembolism risk in acutely ill medical patients?
    Amin AN; Girard F; Samama MM
    Thromb Haemost; 2010 Nov; 104(5):955-61. PubMed ID: 20838741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial.
    Hull RD; Schellong SM; Tapson VF; Monreal M; Samama MM; Nicol P; Vicaut E; Turpie AG; Yusen RD;
    Ann Intern Med; 2010 Jul; 153(1):8-18. PubMed ID: 20621900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleeding complications after systematic switch of routine thromboprophylaxis for major orthopaedic surgery.
    Kistler U; Kramers-de Quervain I; Munzinger U; Kucher N
    Thromb Haemost; 2008 Jun; 99(6):1049-52. PubMed ID: 18521507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fondaparinux for prevention of venous thromboembolism in high-risk trauma patients: a pilot study.
    Lu JP; Knudson MM; Bir N; Kallet R; Atkinson K
    J Am Coll Surg; 2009 Nov; 209(5):589-94. PubMed ID: 19854398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of rivaroxaban or fondaparinux thromboprophylaxis in major orthopedic surgery: findings from the ORTHO-TEP registry.
    Beyer-Westendorf J; Lützner J; Donath L; Radke OC; Kuhlisch E; Hartmann A; Weiss N; Werth S
    J Thromb Haemost; 2012 Oct; 10(10):2045-52. PubMed ID: 22882706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.
    Eriksson BI; Bauer KA; Lassen MR; Turpie AG;
    N Engl J Med; 2001 Nov; 345(18):1298-304. PubMed ID: 11794148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of venous thromboembolism using enoxaparin in day surgery: results of the SMART noninterventional study.
    Haas S; Hohmann V; Bramlage P
    Clin Appl Thromb Hemost; 2012 Jun; 18(3):265-71. PubMed ID: 22084412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Venous thromboembolism prophylaxis after total hip arthroplasty].
    Kučera T; Malý R; Urban K; Sponer P
    Acta Chir Orthop Traumatol Cech; 2011; 78(2):101-5. PubMed ID: 21575551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.
    Raskob GE; Gallus AS; Pineo GF; Chen D; Ramirez LM; Wright RT; Lassen MR
    J Bone Joint Surg Br; 2012 Feb; 94(2):257-64. PubMed ID: 22323697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of fondaparinux in the prevention of venous thromboembolism in elderly medical patients: results of a single-center, retrospective study.
    Silvestri F; Pasca S; Labombarda A; Barbi A; Desideri M; Guidi P; Rogato A; Zaramella M; Bergamo M; Ageno W; Barillari G
    Minerva Med; 2014 Jun; 105(3):221-8. PubMed ID: 24988087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of preventative therapy for venous thromboembolism after coronary artery bypass graft surgery.
    Kulik A; Rassen JA; Myers J; Schneeweiss S; Gagne J; Polinski JM; Liu J; Fischer MA; Choudhry NK
    Circ Cardiovasc Interv; 2012 Aug; 5(4):590-6. PubMed ID: 22739788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of fondaparinux and enoxaparin in acute coronary syndromes.
    ; Yusuf S; Mehta SR; Chrolavicius S; Afzal R; Pogue J; Granger CB; Budaj A; Peters RJ; Bassand JP; Wallentin L; Joyner C; Fox KA
    N Engl J Med; 2006 Apr; 354(14):1464-76. PubMed ID: 16537663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.